AOD 9604s evidence base comes primarily from animal studies Both peptides operate through entirely different biological mechanisms, making a direct comparison challenging AOD 9604 vs Tirzepatide: The Core Difference AOD 9604 is a modified fragment of human growth hormone (specifically amino acids 176-191 with an additional N-terminal tyrosine residue) engineered to isolate the lipolytic domain of hGH while avoiding broader growth hormone receptor activation
Online marketplaces, brick-and-mortar stores, and direct-to-consumer websites sell reputable brands in the $10-$60 range
(2022) Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation Biomedicines, 2022 Oct 25;10(11):2696
Continue as a Guest Directions Of Use Dosage & Administration: Give dose by subcutaneous injection only
Personalized Peptide Protocols with BPC-157 from Rafael Olartecoechea, ARNP What is BPC-157 peptide therapy for weight loss
Watch and podcast next week